198 related articles for article (PubMed ID: 25284583)
21. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
22. Post-Chernobyl incidence of papillary thyroid cancer among Belgian children less than 15 years of age in April 1986: a 30-year surgical experience.
Michel LA; Donckier J; Rosière A; Fervaille C; Lemaire J; Bertrand C
Acta Chir Belg; 2016 Apr; 116(2):101-13. PubMed ID: 27385297
[TBL] [Abstract][Full Text] [Related]
23. Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers.
Achille M; Boukheris H; Caillou B; Talbot M; de Vathaire F; Sabatier L; Desmaze C; Schlumberger M; Soria JC
Am J Clin Oncol; 2009 Feb; 32(1):1-8. PubMed ID: 19194115
[TBL] [Abstract][Full Text] [Related]
24. Gene rearrangements in radiation-induced thyroid carcinogenesis.
Rabes HM
Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
[TBL] [Abstract][Full Text] [Related]
25. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
Kaiser JC; Misumi M; Furukawa K
Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
[TBL] [Abstract][Full Text] [Related]
26. ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout.
Tuttle RM; Lukes Y; Onstad L; Lushnikov E; Abrosimov A; Troshin V; Tsyb A; Davis S; Kopecky KJ; Francis G
Thyroid; 2008 Aug; 18(8):839-46. PubMed ID: 18690796
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiles for radiation-induced thyroid cancer.
Maenhaut C; Detours V; Dom G; Handkiewicz-Junak D; Oczko-Wojciechowska M; Jarzab B
Clin Oncol (R Coll Radiol); 2011 May; 23(4):282-8. PubMed ID: 21411301
[TBL] [Abstract][Full Text] [Related]
28. Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors.
Rogounovitch TI; Saenko VA; Shimizu-Yoshida Y; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Ohtsuru A; Namba H; Tsyb AF; Yamashita S
Cancer Res; 2002 Dec; 62(23):7031-41. PubMed ID: 12460924
[TBL] [Abstract][Full Text] [Related]
29. Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma.
Stephens LA; Powell NG; Grubb J; Jeremiah SJ; Bethel JA; Demidchik EP; Bogdanova TI; Tronko MD; Thomas GA
Thyroid; 2005 Feb; 15(2):100-4. PubMed ID: 15753666
[TBL] [Abstract][Full Text] [Related]
30. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France.
Pacini F; Vorontsova T; Demidchik EP; Molinaro E; Agate L; Romei C; Shavrova E; Cherstvoy ED; Ivashkevitch Y; Kuchinskaya E; Schlumberger M; Ronga G; Filesi M; Pinchera A
J Clin Endocrinol Metab; 1997 Nov; 82(11):3563-9. PubMed ID: 9360507
[TBL] [Abstract][Full Text] [Related]
31. [Thyroid cancer after Chernobyl: is iodine 131 the only culprit ? Impact on clinical practice].
Guiraud-Vitaux F; Elbast M; Colas-Linhart N; Hindie E
Bull Cancer; 2008 Feb; 95(2):191-5. PubMed ID: 18304904
[TBL] [Abstract][Full Text] [Related]
32. A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers.
Port M; Boltze C; Wang Y; Röper B; Meineke V; Abend M
Radiat Res; 2007 Dec; 168(6):639-49. PubMed ID: 18088181
[TBL] [Abstract][Full Text] [Related]
33. Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.
Powell N; Jeremiah S; Morishita M; Dudley E; Bethel J; Bogdanova T; Tronko M; Thomas G
J Pathol; 2005 Apr; 205(5):558-64. PubMed ID: 15714593
[TBL] [Abstract][Full Text] [Related]
34. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
Takahashi M; Saenko VA; Rogounovitch TI; Kawaguchi T; Drozd VM; Takigawa-Imamura H; Akulevich NM; Ratanajaraya C; Mitsutake N; Takamura N; Danilova LI; Lushchik ML; Demidchik YE; Heath S; Yamada R; Lathrop M; Matsuda F; Yamashita S
Hum Mol Genet; 2010 Jun; 19(12):2516-23. PubMed ID: 20350937
[TBL] [Abstract][Full Text] [Related]
35. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
37. Radiation Dose Does Not Affect the Predictive Value of Thyroid Biopsy for Diagnosing Papillary Thyroid Cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
[TBL] [Abstract][Full Text] [Related]
38. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
Lima J; Trovisco V; Soares P; Máximo V; Magalhães J; Salvatore G; Santoro M; Bogdanova T; Tronko M; Abrosimov A; Jeremiah S; Thomas G; Williams D; Sobrinho-Simões M
J Clin Endocrinol Metab; 2004 Sep; 89(9):4267-71. PubMed ID: 15356020
[TBL] [Abstract][Full Text] [Related]
39. Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future?
Tuttle RM; Vaisman F; Tronko MD
Clin Oncol (R Coll Radiol); 2011 May; 23(4):268-75. PubMed ID: 21324656
[TBL] [Abstract][Full Text] [Related]
40. Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC.
Unger K; Malisch E; Thomas G; Braselmann H; Walch A; Jackl G; Lewis P; Lengfelder E; Bogdanova T; Wienberg J; Zitzelsberger H
Oncogene; 2008 Jul; 27(33):4592-602. PubMed ID: 18408749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
